Navigation Links
BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter
Date:1/26/2009

BOTHELL, Wash., Jan. 26 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary GMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced the launch of its new quarterly newsletter BioPreservation Today, a forum for sharing knowledge about optimizing biopreservation protocols and processes, to maximize the yield and function of cells and tissues in research and clinical applications. The launch issue includes articles such as 'Unlocking the Value of a Scientific Advisory Board', 'What is Your Viability Assay Really Saying?', 'Optimizing Biopreservation Yield', and 'Evolution of Best Practices in Biopreservation'.

Mike Rice, BioLife's Chairman and CEO, commented on the publication of the inaugural issue by stating, "We're very pleased to be able to share best practices, state-of-the-art techniques, and steps to optimize biopreservation practices with participants in this field. We're looking forward to providing additional informative and compelling content from guest authors in future issues of BioPreservation Today."

BioLife's Scientific Advisory Board played a role in the development of the newsletter and SAB member Scott R. Burger, MD, founder of Advanced Cell & Gene Therapy, LLC, and a leading consultant to the industry, remarked on the publication by stating, "I've been very impressed with the strides BioLife has made to position the company as a leading biopreservation tools provider. BioPreservation Today will be an effective vehicle to share relevant knowledge within the biopreservation field. Stability and yield of biological raw material and cellular products, and cost per delivered dose, are critical issues that BioLife clearly understands well, and can help hospital transplant labs and commercial companies to overcome, via their products and consulting services."

A downloadable version of the Winter 2009 issue of BioPreservation Today can be found here: http://www.biolifesolutions.com/docs/bpt/bptwinter09.pdf.

BioLife Solutions will be presenting and exhibiting at the Phacilitate Cell & Gene Therapy Forum 2009, January 26-28 in Washington, DC (http://www.phacilitate.co.uk/pages/cgtherapy/index.html).

About BioLife Solutions, Inc.:

BioLife Solutions develops and markets patented hypothermic storage/transport and cryopreservation media products for cells, tissues, and organs. The Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of biopreservation media products are marketed to academic research institutions, hospitals, and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's GMP products are serum-free and protein-free, fully defined, and pre-formulated to reduce preservation-induced, delayed-onset cell damage and death. Comprehensive small animal intravenous safety studies have been completed on HypoThermosol and CryoStor, and both products are supported by US FDA Master Files. BioLife's enabling technology provides research and clinical organizations significantly enhanced in post-preservation cell and tissue viability and function.

For more information please visit http://www.biolifesolutions.com.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

     Media Relations:
     Len Hall
     Allen & Caron Inc.
     (949) 474-4300
     len@allencaron.com

     Investor Relations:
     Matt Clawson
     Allen & Caron Inc.
     (949) 474-4300
     matt@allencaron.com

'/>"/>
SOURCE BioLife Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. BioLife Solutions Expands Scientific Advisory Board
3. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
4. BioLife Solutions Outsourcing Manufacturing, Warehousing, and Order Fulfillment to Bioserv Corporation
5. BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
6. BioLife Solutions Credit Facility Increased to $9 Million
7. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
8. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
9. BioLife Solutions Granted European Biopreservation Patent
10. BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
11. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):